Factory Free sample Swab Rapid Test Antigen - EZER Flu&Covid-19 Antigen Duo rapid test – Genesis
Factory Free sample Swab Rapid Test Antigen - EZER Flu&Covid-19 Antigen Duo rapid test – Genesis Detail:
Introduction
Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar. SARSCoV-2, influenza A and influenza B viral antigens are generally detectable in upper respiratory specimens during the acute phase of infection.
Influenza virus belongs to the family of Orthomyxoviridae, and immunologically diverse, single-stranded RNA viruses. There influenza A and B virus is the main pathogen that severe illnesses both in human and in many animal species. Based on the current epidemiological investigation, the incubation period is 1 to 4 days. The main manifestations include acute fever, general aching and respiratory symptoms. Both Type A and B viruses can circulate simultaneously, but usually one type is dominant during a given season.1
COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
EZERTM Flu & COVID-19 Antigen Duo Rapid Test is intended for the simultaneous qualitative detection and differentiation of the nucleocapsid protein antigens from SARS-CoV-2, influenza A and influenza B in direct nasopharyngeal (NP) specimens. The detection is based on the antibodies which were developed specifically recognizing and reacting with the nucleoprotein of virus.
Detection
EZERTM Flu & COVID-19 Antigen Duo Rapid Test is the simultaneous qualitative detection and differentiation of the nucleocapsid protein antigens from SARS-CoV-2, influenza A and influenza B in direct nasopharyngeal (NP) specimens.
Specimen
Nasopharyngeal
Limit of Detection (LoD)
2019 Novel Coronavirus: 74.8 TCID50/mL
Influenza A
| Influenza Viral Strain |
Calculated |
| A/New Caledonia/20/1999_H1N1 |
8.50×103 |
| A/California/04/2009_H1N1 |
2.11×103 |
| A/PR/8/34_H1N1 |
2.93×103 |
| A/Bean Goose/Hubei/chenhu XVI35-1/2016_H3N2 |
4.94×102 |
| A/Guizhou/54/89_H3N2 |
3.95×102 |
| A/Human/Hubei/3/2005_H3N2 |
2.93×104 |
| A/Bar-headed Goose/QH/BTY2/2015_H5N1 |
1.98×105 |
| A/Anhui/1/2013_H7N9 |
7.90×105 |
Influenza B.
| Influenza Viral Strain |
Calculated |
| B/Victoria |
4.25×103 |
| B/Yamagata |
1.58×102 |
Accuracy
Influenza A
Relative Sensitivity : 86.8%
Relative Specificity: 94%
Accuracy: 92.2%
Influenza B
Relative Sensitivity: 91.7%
Relative Specificity: 97.5%
Accuracy: 96.1%
COVID-19
Relative Sensitivity: 96.6%
Relative Specificity: 100%
Accuracy: 98.9%
Time to results
Read results at 15minutes and no more than 30 minutes.
Kit storage conditions
2~30°C.
Contents
| Test devices | 20 tests |
| Sterilized swabs | 20 pcs |
| Extraction tubes (with 0.5mL extraction | 20 pcs |
| buffer) | 20 pcs |
| Nozzle with filter | 1 pcs |
| Tube Stand | 1 pcs |
Ordering Information
|
Product |
Cat.No. |
Contents |
|
EZERTM Flu & COVID-19 Antigen Duo |
P211137 |
20 Tests |
Product detail pictures:
Related Product Guide:
Now we have highly developed devices. Our items are exported towards the USA, the UK and so on, enjoying a great popularity among the customers for Factory Free sample Swab Rapid Test Antigen - EZER Flu&Covid-19 Antigen Duo rapid test – Genesis , The product will supply to all over the world, such as: kazan, Swaziland, Manchester, Excellent quality, competitive price, punctual delivery and dependable service can be guaranteed. For further inquires please do not hesitate to contact us. Thank you - Your support continuously inspires us.
By Mary from Iraq - 2018.10.09 19:07
In general, we are satisfied with all aspects, cheap, high-quality, fast delivery and good procuct style, we will have follow-up cooperation!
By Meredith from Latvia - 2018.06.03 10:17
